Skip to content
September 28, 2023


Investment information for the new generation

Red Light Holland (TRIP.C) iMicro app exits beta testing and goes live

Red Light Holland (TRIP.C) iMicro app went live after months of beta testing on today, according to a press release.

The application includes Virtual Telecounseling and uses biometric pose detection data to assist people in finding their adequate dosage.

“Our goal is to promote mindfulness and responsible use of microdosing. The iMicro app does that by using the most advanced pose detection technology that can give people objective insights into their body and subconsciousness and by connecting people to the best Microdosing experts in the world. The app also promotes a well-established practice of journaling and does all that while being focused on users privacy. There are too many apps out there that sell users’ data and are not aligned with their users’ well being. Red Light Holland strongly believes that the psychedelic ecosystem needs to be different and we are glad to lead by example with our technology in hopes that other psychedelic companies will follow,” said Sarah Hashkes CTIO of Red Light Holland.

The app’s development took into consideration the latest behavioural science combined with interviews from Microdosing individuals to help understand their pain points. These include adherence to a non-daily dosing regimen, as well as the general lack of a supportive community and the difficulty in finding the dose that’s right for them.

“We are continuing our path as a trailblazing company creating unique technology and intellectual property that we believe will benefit humanity. This app along with the consensual data we get from it will help us build more infrastructure and support structures to promote the responsible use and legalization of psychedelics worldwide,” said Todd Shapiro, Red Light Holland CEO and director.

The site offers personal microdosing assistance over multiple variables, giving the individual a series of dropdown lists to add his or her personal data for a more accessible decision making matrix. A few of the options include goal setting, brand, regimen of preference and a note of caution on how supplements and hormones interact with psilocybin.

—Joseph Morton

Related Posts

More on

Leave a Reply

Your email address will not be published. Required fields are marked *